Impact of intrinsic subtype by PAM50 and other gene signatures on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC) after neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) or bevacizumab (Bev): CALGB 40603/150709 (Alliance)
- Citation:
- Cancer Res vol 75 (suppl 9) S4-5
- Meeting Instance:
- SABCS 2014
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- William M. Sikov William T. Barry Katherine A. Hoadley Brandelyn N. Pitcher Baljit Singh Sara M Tolaney Charles S Kuzma Timothy J Pluard George Somlo Elisa R Port Mehra Golshan Donald A Berry Olwen M Hahn Lisa A Carey Charles M. Perou Clifford A Hudis Eric P Winer
- Networks:
- CA043, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, NY021, RI005, SCOR
- Study
- CALGB-40603
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: